跳至主要内容
临床试验/NCT02217267
NCT02217267已完成3 期

Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain : A Pilot Study

Mahidol University1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2014年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
29
试验地点
1
主要终点
Pain intensity

研究概览

简要总结

The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 months after first time of infusion

详细描述

Peripheral nerve injury may give rise to severe and long-lasting types of pains which are often resistant to treatment such as opioid, tricyclic antidepressant or anticonvulsant. Lidocaine infusion has been the one of intractable neuropathic pain treatment . My hypothesis the serial lidocaine infusion can adequate pain control and can prevent chronic pain (central sensitisation). Therefore, we designed this prospective, randomised, double-blind, controlled study to evaluate the efficacy of serial lidocaine infusion in peripheral neuropathic pain compared with placebo in long term outcome (at 3 month).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Peripheral neuropathic pain from peripheral nerve injury within 6 months after injury
  • Well understand to Thai language in writing or listening

排除标准

  • Underlying Heart disease or Arrhythmia
  • Allergy to lidocaine, Gabapentin, Carbamazepine, tramadol
  • History of epilepsy
  • History of lidocaine used
  • Underlying Psychiatric disease
  • History of drug abuse
  • Pregnancy and nursing

研究组 & 干预措施

Placebo group

Placebo Comparator

Normal Saline 50 ml intravenous infusion in 1 hour once a week 4 times

干预措施: Placebo (Drug)

Lidocaine group

Active Comparator

Lidocaine 3mg/kg in Normal Saline to 50 ml intravenous infusion in 1 hour once a week 4 times

干预措施: Lidocaine (Drug)

结局指标

主要结局

Pain intensity

时间窗: at 3 months after serial lidocaine infusion

Pain intensity (Numerical Rating Scale; from 0-10) 0 means no pain, and 10 means worst pain imaginable.

次要结局

  • Quality of life using Utility score(at 3 month after serial lidocaine infusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验